Biocryst Pharmaceuticals (BCRX) Announces Pricing of Public Offering of Common Stock
11/20/2009 9:06:53 AM
More...
|
Biocryst Pharmaceuticals (BCRX) Announces Proposed Public Offering of Common Stock
11/17/2009 11:09:28 AM
More...
|
Biocryst Pharmaceuticals (BCRX) to Present at Oppenheimer Healthcare Conference
10/30/2009 9:55:19 AM
More...
|
Biocryst Pharmaceuticals (BCRX) Reports Third Quarter 2009 Financial Results and Provides Corporate Update
10/29/2009 8:58:15 AM
More...
|
Severe Swine Flu Patients Eligible for Biocryst Pharmaceuticals (BCRX) Drug, FDA Says
10/26/2009 8:00:34 AM
More...
|
Biocryst Pharmaceuticals (BCRX) to Announce Third Quarter 2009 Financial Results on October 29, 2009
10/22/2009 10:43:46 AM
More...
|
Biocryst Pharmaceuticals (BCRX) Provides Update Regarding Peramivir for Influenza
10/1/2009 9:08:29 AM
More...
|
Biocryst Pharmaceuticals (BCRX) Announces Initiation of Phase 2 Study of BCX4208 for the Treatment of Gout
9/28/2009 8:38:00 AM
More...
|
Biocryst Pharmaceuticals (BCRX) Receives Peramivir Request for Proposal From the U.S. Government
9/21/2009 10:26:03 AM
More...
|
Biocryst Pharmaceuticals (BCRX) Makes Flu Drug Marketing Deals in Four Countries
9/15/2009 7:46:11 AM
More...
|
|